Moreover, 6-shogaol also decreases the PhIP-786-O-CM-induced RANKL expression in osteoblasts, suggesting that 6-shogaol might be a potential agent for preventing the aggravating effect of PhIP on renal cell carcinoma bone metastasis. Here, TNFSF11 is linked to renal cell carcinoma.